Small Fiber Neuropathy (SFN) is a condition that generally affects the nervous system and is marked by severe pain attacks. It occurs when damage to the peripheral nerves predominantly or entirely affects the small myelinated (Aδ) fibers or unmyelinated C fibers thus called Small Fiber Peripheral Neuropathy. It generally affects the small nerve fibers present in the skin and those responsible to mediate pain and thermal sensation. The specific fiber types involved in this process include both small somatic and autonomic fibers.
DelveInsight's "Small Fiber Neuropathy (SFN) Market Insights, Epidemiology, and Market Forecast 2030" report delivers an in-depth understanding of the Small Fiber Neuropathy (SFN), historical and forecasted epidemiology as well as the Small Fiber Neuropathy (SFN) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Small Fiber Neuropathy (SFN) Market Key Facts
-
An epidemiological study in SFN has been performed in the Netherlands. It showed an overall minimum incidence of 12 cases per 100,000 inhabitants per year with long-term persistent complaints about the study period of 2010-2011 (Peters et al., 2013). It is significantly higher than the reported incidence rates of inflammatory large-fiber neuropathies.
-
According to DelveInsight’s analysis, Small Fiber Neuropathy (SFN) is more common in males than females.
-
Among the 7mm, the United States has the highest percentage of prevalent diagnosed & treated patients.
Small Fiber Neuropathy (SFN) Market Trends and Growth Analysis
The Small Fiber Neuropathy (SFN) Market Size is anticipated to increase during the study period. The key driver for the surge in market size is the rise in the number of Prevalent cases. Further increasing prevalence, along with a meticulous understanding of the disease are fueling the growth of the market in the 7MM.
The Small Fiber Neuropathy (SFN) market outlook section of the report helps to build the detailed comprehension of the historic, current, and forecasted Small Fiber Neuropathy (SFN) market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
Owing to the launch of emerging therapies, the market scenario of Small Fiber Neuropathy (SFN) is expected to change significantly in the coming years. Some of the key players in the Small Fiber Neuropathy (SFN) market include:
Vertex Pharmaceuticals Incorporated
Biogen
Takeda
And many others.
For more detailed information on Small Fiber Neuropathy (SFN) Market Trends and Growth Analysis, visit:
https://www.delveinsight.com/report-store/small-fiber-neuropathy-market